Improved overall survival in classical Hodgkin lymphoma across therapeutic eras: A National Cancer Database study
Improved overall survival in classical Hodgkin lymphoma across therapeutic eras: A National Cancer Database study.
the study reports that patients with classical Hodgkin lymphoma now achieve longer overall survival over time as therapies have evolved, suggesting that advancements in treatment have positively impacted patient outcomes.
Bizonyítékszint: Klinikai vizsgálat. Formális klinikai vizsgálati eredmény.
Kapcsolódó jelek
- Advanced Classical Hodgkin Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study Group.
- Overcoming PD‑1 Resistance in Relapsed/Refractory Hodgkin Lymphoma
- Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era
- Combination of Acimtamig and AlloNK Effective in R/R Classical Hodgkin Lymphoma
- Working towards harmonization of clinical trial reporting in Hodgkin lymphoma